# BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer)

> **NCT03628859** · — · UNKNOWN · sponsor: **Centre Leon Berard** · enrollment: 30 (estimated)

## Conditions studied

- Renal Cancer Metastatic

## Interventions

- **BIOLOGICAL:** Immunological and tumour characterization

## Key facts

- **NCT ID:** NCT03628859
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-21
- **Primary completion:** 2023-06
- **Final completion:** 2023-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03628859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03628859, "BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03628859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*